M&A Deal Summary

Medtronic Acquires Ardian

On January 13, 2011, Medtronic acquired healthcare services company Ardian from MPE Partners for 800M USD

Acquisition Highlights
  • This is Medtronic’s 2nd transaction in the Healthcare Services sector.
  • This is Medtronic’s 6th largest (disclosed) transaction.
  • This is Medtronic’s 22nd transaction in the United States.
  • This is Medtronic’s 10th transaction in California.

M&A Deal Summary

Date 2011-01-13
Target Ardian
Sector Healthcare Services
Buyer(s) Medtronic
Sellers(s) MPE Partners
Deal Type Add-on Acquisition
Deal Value 800M USD

Target

Ardian

Mountain View, California, United States
Ardian, Inc. is a developer of catheter-based therapies to treat hypertension and related conditions. Ardian is the eighth company created by The Foundry, a leading medical device incubator.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Medtronic

Dublin, Ireland

Category Company
Founded 1949
Sector Medical Products
Employees95,000
Revenue 32.4B USD (2024)
DESCRIPTION
Medtronic's operational headquarters in Fridley, Minnesota.
Medtronic's operational headquarters in Fridley, Minnesota.

Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. It serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Dublin, Ireland with its operational headquarters in Fridley, Minnesota.


DEAL STATS #
Overall 25 of 59
Sector (Healthcare Services) 2 of 4
Type (Add-on Acquisition) 25 of 57
State (California) 10 of 21
Country (United States) 22 of 44
Year (2011) 1 of 3
Size (of disclosed) 6 of 36
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-11-16 Osteotech

Eatontown, New Jersey, United States

Osteotech, Inc. is a provider of biologic solutions for regenerative medicine to support surgeons and their patients in the repair of the musculoskeletal system through the development of innovative therapy-driven products that alleviate pain, promote biologic healing and restore function. Osteotech was formed in 1986 and is based in Eatontown, New Jersey.

Buy $123M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-07 PEAK Surgical

Palo Alto, California, United States

PEAK Surgical, Inc. is a medical device company that has developed the PEAK PlasmaBlade®, a new tissue dissection device based on a proprietary technology that represents an important advance in advanced energy surgical technologies. The PlasmaBlades are a family of disposable cutting devices that offer the exacting control of a scalpel and the bleeding control of traditional electrosurgery without extensive collateral damage. These surgical devices come together with the PULSAR® Generator, which supplies pulsed plasma radiofrequency energy to the PlasmaBlades, to form the PEAK® Surgery System.

Buy $120M

Seller(S) 1

SELLER

MPE Partners

Cleveland, Ohio, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1968
PE ASSETS 3.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

MPE Partners is a Midwest based investment firm principally focused private equity investments throughout North America. MPE has a preference for buyouts and recapitalizations of lower middle-market, family and entrepreneur owned businesses. The Firm looks for stand-alone companies operating in the 'high-value' manufacturing or business services sectors. MPE seeks businesses with at least $5 million of EBITDA and valued up to $250 million. MPE Partners is headquartered in Cleveland, Ohio.


DEAL STATS #
Overall 32 of 58
Sector (Healthcare Services) 2 of 2
Type (Add-on Acquisition) 14 of 27
State (California) 15 of 23
Country (United States) 30 of 56
Year (2011) 1 of 3
Size (of disclosed) 3 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-06 FoldRx Pharmaceuticals

Cambridge, Massachusetts, United States

FoldRx Pharmaceuticals is a development and discovery company focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding and aggregation (amyloidosis). The Company's lead product, FX-4006, has begun a Phase II/III study in familial amyloid polyneuropathy. FoldRx Pharmaceuticals was founded in 2003 and is based in Cambridge, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-07 Ryan Herco Flow Solutions

Burbank, California, United States

Ryan Herco Flow Solutions, Inc. is a distributor of corrosion-resistant fluid handling, filtration and flow control products in the United States with a growing presence in Asia. Ryan Herco Flow Solutions was founded in 1948 and is based in Burbank, California.

Sell -